Clinical trial
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
NCT05101018 is registered in ClinicalTrials.gov with James J. Peters Veterans Affairs Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
- Lead sponsor
- James J. Peters Veterans Affairs Medical Center
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- November 1, 2021
- Completion date
- November 1, 2027
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.